FDA Recalls Depo-Medrol Injectable Due to Temperature Abuse in Manufacturing
McKesson Medical-Surgical is recalling DEPO-MEDROL (methylprednisolone acetate) injectable suspension nationwide due to temperature abuse during manufacturing that may have affected product quality. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. Temperature abuse during manufacturing poses a theoretical risk to product quality and efficacy of a prescription medication, meeting the criterion for a risk-of-harm product without yet-reported injury.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling DEPO-MEDROL (methylprednisolone acetate) 40 mg/mL injectable suspension nationwide. The affected product is a prescription corticosteroid used for intra-articular, intralesional, intramuscular, and soft tissue injections.
The recall was initiated due to current Good Manufacturing Practices (cGMP) deviations involving temperature abuse during manufacturing. McKesson Medical-Surgical is unable to identify specific lot numbers received by individual customers, and notification letters have been sent to affected customers with information about distribution and shipment dates.
Healthcare providers and pharmacies should discontinue use of the recalled product immediately and contact their supplier for return instructions. Patients who have received this medication should consult their healthcare provider before making any changes to their treatment. No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- DEPO-MEDROL (METHYLPREDNISOLONE ACETATE)
- Brand
- DEPO-MEDROL
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Injectable Corticosteroid
- Affected units
- 2
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same brand · DEPO-MEDROL
- ModerateDepo-Medrol injectable suspension recalled for manufacturing temperature control deviations
FDA (Drugs) · 2022-06-15
- LowPfizer Recalls Depo-Medrol Vials Due to pH Specification Failure
FDA (Drugs) · 2014-08-20
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18